Company Quick10K Filing
Bionik Laboratories
10-Q 2020-09-30 Filed 2020-11-12
10-Q 2020-06-30 Filed 2020-08-12
10-K 2020-03-31 Filed 2020-06-29
10-Q 2019-12-31 Filed 2020-02-14
10-Q 2019-09-30 Filed 2019-11-14
S-1 2019-09-16 Public Filing
10-Q 2019-06-30 Filed 2019-08-12
10-K 2019-03-31 Filed 2019-07-01
10-Q 2018-12-31 Filed 2019-02-11
S-1 2018-10-29 Public Filing
10-Q 2018-09-30 Filed 2018-11-13
10-Q 2018-06-30 Filed 2018-08-14
10-K 2018-03-31 Filed 2018-06-27
10-Q 2017-12-31 Filed 2018-02-13
10-Q 2017-09-30 Filed 2017-11-13
10-Q 2017-06-30 Filed 2017-08-14
10-K 2017-03-31 Filed 2017-06-29
10-Q 2016-12-31 Filed 2017-02-14
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-K 2015-12-31 Filed 2016-03-18
10-Q 2015-09-30 Filed 2015-11-12
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-20
10-K 2014-12-31 Filed 2015-04-15
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-04-15
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-03-06
10-Q 2012-09-30 Filed 2012-11-19
10-Q 2012-08-07 Filed 2012-08-07
10-Q 2012-03-31 Filed 2012-05-15
10-K 2011-12-31 Filed 2012-04-11
10-Q 2011-09-30 Filed 2011-11-21
8-K 2020-11-24
8-K 2020-11-12
8-K 2020-10-06
8-K 2020-10-05
8-K 2020-09-30
8-K 2020-08-13
8-K 2020-07-06
8-K 2020-06-30
8-K 2020-06-25
8-K 2020-06-03
8-K 2020-05-18
8-K 2020-05-06
8-K 2020-03-23
8-K 2020-02-14
8-K 2020-01-30
8-K 2020-01-22
8-K 2019-11-15
8-K 2019-10-14
8-K 2019-09-24
8-K 2019-09-03
8-K 2019-08-13
8-K 2019-08-01
8-K 2019-07-25
8-K 2019-07-17
8-K 2019-07-12
8-K 2019-07-08
8-K 2019-06-27
8-K 2019-06-18
8-K 2019-06-11
8-K 2019-05-28
8-K 2019-05-15
8-K 2019-05-13
8-K 2019-05-08
8-K 2019-03-28
8-K 2019-03-18
8-K 2019-02-13
8-K 2019-02-11
8-K 2019-01-23
8-K 2019-01-22
8-K 2019-01-04
8-K 2018-12-18
8-K 2018-12-14
8-K 2018-11-13
8-K 2018-10-31
8-K 2018-10-30
8-K 2018-10-26
8-K 2018-10-22
8-K 2018-10-10
8-K 2018-09-07
8-K 2018-08-14
8-K 2018-08-07
8-K 2018-08-01
8-K 2018-07-20
8-K 2018-07-16
8-K 2018-07-09
8-K 2018-06-28
8-K 2018-06-27
8-K 2018-06-22
8-K 2018-06-21
8-K 2018-06-11
8-K 2018-06-11
8-K 2018-05-24
8-K 2018-05-16
8-K 2018-05-10
8-K 2018-04-26
8-K 2018-04-20
8-K 2018-04-12
8-K 2018-03-29
8-K 2018-03-22
8-K 2018-03-14
8-K 2018-03-08
8-K 2018-03-06
8-K 2018-02-09
8-K 2018-01-30
8-K 2018-01-24
8-K 2018-01-19
8-K 2018-01-09
8-K 2017-12-29

Bionik Laboratories Financials

BNKL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
1Life Healthcare (ONEM)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
20 20 Global (TWGL)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
21st Century Oncology Holdings (RTSX)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
024 Pharma (EEIG)

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash8121116512123467936,1259,0787,8596,6175,3822,7501,6775815448461369995079609603063754475304,675
Accounts Receivable0012094254384135373072133703705181,5211,5231,027481
Inventory2602941952282562313022371561561933364065821,037
PP&E143179178183186424339371595611612612617625625630643718761810
Assets8121116512123467936,4269,5498,4287,2386,23731,37630,34929,31628,96928,89327,95929,03928,58529,08429,08428,90031,02330,67830,23135,234
Accounts Payable2091971311353213774204057858919577957257367369061,3941,1491,0551,434
Long-Term Debt066063263281,454
Liabilities666726071014172224435422302506,2605,9737,4125,3915,0025,7786,3667,08510,3088,1225,1425,1422,0036,3183,2704,6563,260
Stockholders' Equity2649360-5-7-10-11-14-16-395,8849,3198,17997826423,96424,95824,31423,19122,52720,87318,73120,46323,94223,94226,89724,70527,40825,57531,975
Income Statement ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue41511222222164183721888222261417
Cost of Revenue5912335-1729608822525325338445054333683
Gross Profit1056383558162173192248248163480725454198
R&D436610768-3243444188145728606868305468786776776797791,040817886
SG&A2630134734253181683243721,3631,4391,3867657871,5971,0731,9411,2161,3451,5221,5221,3591,5371,8141,4251,785
Tax00000000000
Net Income1-5-21-12-3-6-2-3-1-4-1-24-1,247-2,419-1,177-761-1,004-2,323-589-811-1,532-2,245-3,611-2,581-6,189-761-7615,5053,4292,121-3,383
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-4-2-11-411-13-1-1-0-11-825-1,458-1,066-1,240-1,038-2,898-2,926-1,577-1,451-1,307-2,156-2,495-2,421-2,421-2,390-1,353-1,324-3,427
Cash Investing000-39-175-149-17-1970190-3-161-160-4-8-8-6-76-43-48
Cash Financing9000001423256,7894,5520002672674831,5751,6253,0182,0082,8812,8811,7421,5001,4507,620